Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

David M Kern1,2,3, Ben Sorum1,2,3, Sonali S Mali1,2

  • 1Department of Molecular & Cell Biology, University of California Berkeley, Berkeley, CA, USA.

Insights

The SARS-CoV-2 ORF3a protein functions as an ion channel. Inhibiting this viral protein could lead to new treatments for COVID-19 and other coronavirus diseases.

Area of Science:

  • Virology
  • Structural Biology
  • Molecular Biology

Background:

  • The SARS-CoV-2 ORF3a protein is a viral ion channel involved in key pathogenic processes.
  • The 3a protein and antibodies against it are present in infected patients.
  • Targeting the 3a protein in SARS-CoV-1 reduced viral load and disease severity in animal models.

Purpose of the Study:

  • To determine the structure of the SARS-CoV-2 3a protein using cryo-electron microscopy.
  • To investigate the ion channel activity of the 3a protein.
  • To identify potential therapeutic inhibitors of 3a protein function.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) for structure determination.
  • Electrophysiology and fluorescent ion imaging in reconstituted liposomes.
  • Site-directed mutagenesis to study ion permeability.

Main Results:

  • The SARS-CoV-2 3a protein was resolved to 2.1-Å resolution, revealing a novel fold with distinct openings.
  • The protein exhibits Ca2+-permeable, nonselective cation channel activity.
  • Specific mutations were found to alter ion permeability, and polycationic compounds were identified as inhibitors.

Conclusions:

  • The 3a protein's structure and ion channel activity provide insights into its role in viral pathogenesis.
  • 3a-like proteins are conserved across various coronaviruses, suggesting broad therapeutic potential.
  • Targeting the SARS-CoV-2 3a protein offers a promising strategy for developing treatments against COVID-19 and other coronavirus infections.